Waltonitone induces human hepatocellular carcinoma cells apoptosis in vitro and in vivo

Cancer Letters

Volumn 286, Issue 2, 2009, Pages 223-231

  Zhang, Zhang ^a,b   Wang, Shuo ^b   Qiu, Hong ^b   Duan, Chaohui ^a   Ding, Kan ^b   Wang, Zhengtao ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Apoptosis; Caspase; Gentiana waltonii Burkill; Hepatocellular carcinoma; Waltonitone

Indexed keywords

ANTINEOPLASTIC AGENT; DEATH RECEPTOR; PROTEIN BCL 2; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; WALTONITONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MITOCHONDRION; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL;

ALKALOIDS; ANIMALS; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; MOLECULAR STRUCTURE; QUINOLINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

GENTIANA; MUS;

EID: 71649088587     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.05.023     Document Type: Article

References (39)

1. Motola-Kuba D., Zamora-Valdes D., Uribe M., and Mendez-Sanchez N. Hepatocellular carcinoma: an overview. Ann. Hepatol. 5 (2006) 16-24
2. Colombo M. Natural history of hepatocellular carcinoma. Ann. Ital. Chir. 79 (2008) 91-97
3. Gish R.G., and Baron A. Hepatocellular carcinoma (HCC): current and evolving therapies. IDrugs 11 (2008) 198-203
4. Ye S.L. Current aspects on standard therapy for primary hepatocellular carcinoma. Chinese J. Hepatol. 16 (2008) 1-2
5. Poupon R., Fartoux L., and Rosmorduc O. Therapeutic advances in hepatocellular carcinoma. Bull. Acad. Natl. Med. 192 (2008) 23-32
6. Normile D. Asian medicine: the new face of traditional Chinese medicine. Science 299 (2003) 188-190
7. Jiang W.Y. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends. Pharmacol. Sci. 26 (2005) 558-563
8. Yuan R., and Lin Y. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol. Ther. 86 (2000) 191-198
9. Chen Y.Y., and Liang J.Y. Research progress on Gentiana L. Strait. Pharm. J. 20 (2008) 1-4
10. Jiang W.X., and Xue B.Y. Hepatoprotective effects of Gentiana scabra on the acute liver injuries in mice. China J. Chinese Materia. Medica. 30 (2005) 1105-1107
11. Duan C.H., Shi B.J., Wu L.H., Chou G.X., and Wang Z.T. Chemical constituents of Gentiana waltonii. China J. Nat. Med. 5 (2007) 417-420
12. Ovesna Z., Vachalkova A., Horvathova K., and Tothova D. Pentacyclic triterpenoic acids: new chemoprotective compound. Neoplasma 51 (2004) 327-333
13. Safayhi H., and Sailer E.R. Anti-inflammatory actions of pentacyclic triterpenes. Planta Med. 63 (1997) 487-493
14. Alakurtti S., Makela T., Koskimies S., and Yli-Kauhaluoma J. Pharmacological properties of the ubiquitous natural product betulin. Eur. J. Pharm. Sci. 29 (2006) 1-13
15. Ikeda Y., Murakami A., and Ohigashi H. Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol. Nutr. Food Res. 52 (2008) 26-42
16. Huang L., and Chen C.H. Molecular targets of anti-HIV-1 triterpenes. Curr. Drug Targets Infect. Disord. 2 (2002) 33-36
17. Liu J. Oleanolic acid and ursolic acid: research perspectives. J. Ethnopharmacol. 100 (2005) 92-94
18. Ikeda Y., Murakami A., and Ohigashi H. Ursolic acid promotes the release of macrophage migration inhibitory factor via ERK2 activation in resting mouse macrophages. Biochem. Pharmacol. 70 (2005) 1497-1505
19. Harmand P.O., Duval R., Delage C., and Simon A. Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. Int. J. Cancer 114 (2005) 1-11
20. You H.J., Choi C.Y., Kim J.Y., Park S.J., Hahm K.S., and Jeong H.G. Ursolic acid enhances nitric oxide and tumor necrosis factor-alpha production via nuclear factor-kappaB activation in the resting macrophages. FEBS Lett. 509 (2001) 156-160
21. Lee J.S., Chu I.S., Heo J., Calvisi D.F., Sun Z., Roskams T., Durnez A., Demetris A.J., and Thorgeirsson S.S. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40 (2004) 667-676
22. Walzer N., and Kulik L.M. Hepatocellular carcinoma: latest developments. Curr. Opin. Gastroenterol. 24 (2008) 312-319
23. Meier P., Finch A., and Evan G. Apoptosis in development. Nature 407 (2000) 796-801
24. Kountouras J., Zavos C., and Chatzopoulos D. Apoptosis in hepatocellular carcinoma. Hepatogastroenterology 50 (2003) 242-249
25. Ghavami S., Hashemi M., Kadkhoda K., Alavian S.M., Bay G.H., and Los M. Apoptosis in liver diseases-detection and therapeutic applications. Med. Sci. Monit. 11 (2005) RA337-345
26. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972) 239-257
27. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
28. Eichhorst S.T. Modulation of apoptosis as a target for liver disease. Expert Opin. Ther. Tar. 9 (2005) 83-99
29. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., and Williams L.T. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278 (1997) 294-298
30. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., and Lazebnik Y.A. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376 (1995) 37-43
31. Budihardjo I., Oliver H., Lutter M., Luo X., and Wang X. Biochemical pathways of caspase activation during apoptosis. Ann. Rev. Cell Dev. Biol. 15 (1999) 269-290
32. Leist M., and Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2 (2001) 589-598
33. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
34. Susin S.A., Zamzami N., and Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta 1366 (1998) 151-165
35. Petit P.X., Zamzami N., L J., Vayssiere, Mignotte B., Kroemer G., and Castedo M. Implication of mitochondria in apoptosis. Mol. Cell Biochem. 174 (1997) 185-188
36. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
37. Yoon J.H., and Gores G.J. Death receptor-mediated apoptosis and the liver. J. Hepatol. 37 (2002) 400-410
38. Schmitz I., Kirchhoff S., and Krammer P.H. Regulation of death receptor-mediated apoptosis pathways. Int. J. Biochem. Cell Biol. 32 (2000) 1123-1136
39. Youle R.J., and Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9 (2008) 47-59